Ionis Pharmaceuticals (IONS) Tops Q2 EPS by 48c

Ionis Pharmaceuticals (NASDAQ: IONS) reported Q2 EPS of ($0.45), $0.48 better than the analyst estimate of ($0.93). Revenue for the quarter came in at $225 million versus the consensus estimate of $152.34 million.

For earnings history and earnings-related data on Ionis Pharmaceuticals (IONS) click here.

You May Also Be Interested In

• Gulfport Energy and Mobility Global to join S&P SmallCap 600
• Tractor Supply and Starlink team up to expand rural broadband via 4-H
• Tianci International updates Zimbabwe gold and chromium project progress